BONRAYBIO CO., LTD.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
1. LensHooke X3 PRO Semen Quality Analyzer
2. LensHooke X12 PRO Semen Analysis System
3. LensHooke X1 PRO Semen Quality Analyzer
2. LensHooke X12 PRO Semen Analysis System
3. LensHooke X1 PRO Semen Quality Analyzer
Founded Year
2016
Unified Business No.
42686138
Status
Active
Number of Employees
0
Total Paid-in
Capital
248,007,850 (NT$)
Location of Company
Taiwan
, Taichung City
Exit Status
Emerging Stock Exchange(2023)、Innovation Board(2024)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Bonraybio is a team formed by the engineers & scientist with more than 10 years' experience in medical instrument development field. We are dedicated to the development of high-precision and user-friendly medical instrument and solution to assist to improve the medical quality around the world.
Recently, the aging population and the increasing number of infertility have led to problems in social, economic, and many other aspects. The population is a basic index to evaluate the competitive strength of a country. Therefore, to increase the fertility rate has become one of the important issues for most of the countries. However, most of companies are all dedicated on female factor, the research or solution of male factor are quite limited.
Therefore, we create the LensHooke. From 2016, LensHooke has developed and introduced its basic semen analysis, advanced sperm DNA Fragmentation and also the sperm separation solutions to the market successfully.
Recently, the aging population and the increasing number of infertility have led to problems in social, economic, and many other aspects. The population is a basic index to evaluate the competitive strength of a country. Therefore, to increase the fertility rate has become one of the important issues for most of the countries. However, most of companies are all dedicated on female factor, the research or solution of male factor are quite limited.
Therefore, we create the LensHooke. From 2016, LensHooke has developed and introduced its basic semen analysis, advanced sperm DNA Fragmentation and also the sperm separation solutions to the market successfully.
